It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Severe febrile illnesses in children encompass life-threatening organ dysfunction caused by diverse pathogens and other severe inflammatory syndromes. A comparative approach to these illnesses may identify shared and distinct features of host immune dysfunction amenable to immunomodulation. Here, using immunophenotyping with mass cytometry and cell stimulation experiments, we illustrate trajectories of immune dysfunction in 74 children with multi-system inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2, 30 with bacterial infection, 16 with viral infection, 8 with Kawasaki disease, and 42 controls. We explore these findings in a secondary cohort of 500 children with these illnesses and 134 controls. We show that neutrophil activation and apoptosis are prominent in multi-system inflammatory syndrome, and that this is partially shared with bacterial infection. We show that memory T cells from patients with multi-system inflammatory syndrome and bacterial infection are exhausted. In contrast, we show viral infection to be characterized by a distinct signature of decreased interferon signaling and lower interferon receptor gene expression. Improved understanding of immune dysfunction may improve approaches to immunomodulator therapy in severe febrile illnesses in children.
Severe febrile illnesses in children may be various in presentation and aetiology but involve immune dysfunction amenable to immunomodulation. Here, the authors identify shared neutrophil and T cell dysfunction and a distinct interferon signature in critically ill children with severe febrile illness.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


















1 Imperial College London, Section of Infectious Diseases, Department of Medicine, St Mary’s Hospital Campus, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
2 St Thomas’ Hospital, Department of Women and Children’s Health, School of Life Course and Population Sciences, King’s College London, London, UK (GRID:grid.425213.3); Guy’s and St Thomas’ NHS Foundation Trust, Paediatric Intensive Care, Evelina London Children’s Hospital, London, UK (GRID:grid.420545.2) (ISNI:0000 0004 0489 3985)
3 Great Maze Pond, School of Immunology and Microbial Sciences, King’s College London, Guy’s Hospital, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
4 Great Maze Pond, Advanced Cytometry Platform (Flow Core), Research and Development Department at Guy’s and St Thomas’ NHS Foundation Trust, Guy’s Hospital, London, UK (GRID:grid.239826.4) (ISNI:0000 0004 0391 895X); Charterhouse Square, Flow Cytometry Core, Barts Cancer Centre, Queen Mary University of London, John Vane Science Centre, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133)
5 Great Maze Pond, Advanced Cytometry Platform (Flow Core), Research and Development Department at Guy’s and St Thomas’ NHS Foundation Trust, Guy’s Hospital, London, UK (GRID:grid.239826.4) (ISNI:0000 0004 0391 895X)
6 Guy’s and St Thomas’ NHS Foundation Trust, Paediatric Intensive Care, Evelina London Children’s Hospital, London, UK (GRID:grid.420545.2) (ISNI:0000 0004 0489 3985)
7 Evelina London Children’s Hospital, Paediatric Immunology and Infectious Diseases, London, UK (GRID:grid.483570.d) (ISNI:0000 0004 5345 7223)
8 St Thomas’ Hospital, Department of Women and Children’s Health, School of Life Course and Population Sciences, King’s College London, London, UK (GRID:grid.425213.3)
9 Lewisham and Greenwich NHS Foundation Trust, Children’s Services, London, UK (GRID:grid.451052.7) (ISNI:0000 0004 0581 2008)
10 Imperial College London, Department of Surgery and Cancer, St Mary’s Hospital Campus, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
11 Departement de l’Essone, Institut de la Biologie de la cellule, Université Paris Saclay, Gif-sur-Yvette, Gif-sur-Yvette, France (GRID:grid.460789.4) (ISNI:0000 0004 4910 6535)
12 Little France Crescent, Institute for Regeneration and Repair, Centre for Inflammation Research, University of Edinburgh, Edinburgh Royal Infirmary, Edinburgh, UK (GRID:grid.418716.d) (ISNI:0000 0001 0709 1919)